Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-06-27 @ 5:44 PM
Study NCT ID:
NCT00879333
Status:
COMPLETED
Last Update Posted:
2015-11-03
First Post:
2009-04-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CRAD001R2301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None